| Analytik Jena–PERSON: investment, 201410 DIVESTMENT Klaus Berka to sell his shares to Endress+Hauser (Deutschland) GmbH & Co KG |
2014-10-01 |
| Analytik Jena–Thuringia (govt): investment, 201410 DIVESTMENT TIB to sell shares in AJ to Endress+ Hauser (Deutschland) AG & Co KG |
2014-10-01 |
| Bayer–Belchim Crop Protection: fungicide, 201410– acquisition sole European distribution rights €na for biofungicide Contans WG by Bayer CropScience |
2014-10-01 |
| Bayer–Univ Kyoto: drug discovery, 201410–201609 collab 2y to jointly identify drug candidates of KU-SACI + Bayer Open Innovation Center Japan |
2014-10-01 |
| Curasan–SEVERAL: investment, 201410 capital increase w subscription rights €1.5m |
2014-10-01 |
| Imevax–Germany (govt): grant, 201410 GO-Bio Phase II grant €5.9m from BMBF |
2014-10-01 |
| Merck (US)–Bayer: OTC drugs, 201410 acquisition $14.2b in cash of Merck’s consumer care business incl Claritin by Bayer |
2014-10-01 |
| Merck (US)–Bayer: sGC modulators, 201410– collab strategic alliance ww co-developm + co-commercialisation $1b upfront + $1.1b milestones |
2014-10-01 |
| Multi Channel Systems MCS–Harvard Bioscience: investment, 201410 acquisition €7.5m in cash by Harvard Bioscience |
2014-10-01 |
| SAW Instruments–NanoTemper: investment, 201410 acquisition by NanoTemper Technologies GmbH |
2014-10-01 |
| Life Sciences Partners–SEVERAL: investment, 201409 launch €80m LSP 5 fund with target size of €150m |
2014-09-30 |
| Metrohm–Ecknauer & Schoch: public relations, 201409 service existent |
2014-09-29 |
| Shimadzu–m/e Brand Communication: public relations, 201409 service existent |
2014-09-29 |
| Probiodrug–SEVERAL: investment, 201409–201410 IPO €23.2m at Euronext Amsterdam |
2014-09-25 |
| Fuchs Petrolub–BRAIN: lubricant, 201409– collab development of lubricants produced from renewable raw materials |
2014-09-24 |
| Molecular Partners–SEVERAL: investment, 201409–201412 IPO CHF106.2m at SIX Swiss Exchange |
2014-09-23 |
| Sigma-Aldrich–Merck (DE): investment, 201409–201511 acquisition $17b in cash |
2014-09-22 |
| Analytik Jena–Endress+Hauser: investment, 201409–201410 acquisition of addit 27.56% from Klaus Berka + TIB rasing share to 82.22% |
2014-09-18 |
| Boehringer–CureVac: RNActive vaccine, 20140901– collab developm + excl ww license for CV9202 €35m upfront + €430m milestones + royalties |
2014-09-18 |
| Cardiorentis–HealthCare Royalty Partners: financing, 201409 financing agreement €45m with undislosed features |
2014-09-17 |
| OSE Pharma–SEVERAL: investment, 201409–201503 IPO €21.1m at Euronext Paris |
2014-09-17 |
| Merck (DE)–Lupin: pharmaceuticals, 201409– strategic alliance €na developm + dossiers + supply by Lupin + marketing Merck Serono in emerging markets |
2014-09-16 |
| MorphoSys–Germany (govt): grant, 201409– BMBF grant up to €1m to develop Ylanthia antibodies against two undisclosed GPCR targets |
2014-09-15 |
| Nobel Biocare–Danaher: investment, 201409–201412 public cash tender offer CHF17/share w total value of $2.2b incl debt assumed + net of cash acquired |
2014-09-15 |
| SensoQuest–Eppendorf: thermal cycler, 201409– license covering gradient technology for thermal cyclers to SensoQuest GmbH |
2014-09-15 |
| Abbott–Biocartis: molecular diagnostics, 201409 collab existent development of diagnostic tests with Abbott Molecular |
2014-09-12 |
| Boehringer–Minapharm: rec protein production technology, 201409 license existent from ProBioGen |
2014-09-09 |
| Novartis–Minapharm: rec protein production technology, 201409 license existent from ProBioGen |
2014-09-09 |
| Vexim–LifeSci: public relations, 201409 service existent by LifeSci Advisors |
2014-09-08 |
| Zürcher Kantonalbank–Bellevue: investment, 201409– acquisition 100% of Adamant Biomedical Investments AG from ZKB |
2014-09-05 |
| Biocartis–SEVERAL: investment, 201409 financing round €64.5m from JnJ + Hitachi + PMV Tina Fund + family offices |
2014-09-04 |
| MyCartis–SEVERAL: investment, 201409 1st financing round €15m from RMM + Valiance + Biover II |
2014-09-04 |
| Pronota–Biocartis: investment, 201409 merger of Pronota with spun-out Swiss Evaluation business of Biocartis to form MyCartis |
2014-09-04 |
| 4SC–Yorkville Group: credit, 201409 second tranche €500k convertible notes under up to €15m agreem from 2/14 w YA Global Master SPV Ltd |
2014-09-03 |
| Nabriva–Hume Brophy: public relations, 201409 service existent by Hume Brophy |
2014-09-03 |
| Affimed–Perceptive Advisors: credit, 201409– loan agreem over €10.5m |
2014-09-02 |
| Affimed–SEVERAL: investment, 201409 financing round Series E €11.7m led by existing investors |
2014-09-02 |
| BeiGene–Boehringer: biopharmaceuticals, 201409– strategic supply + manufacturing agreem for biopharmaceuticals using mammalian cell culture technology |
2014-09-02 |
| Merck (DE)–S-Target Therapeutics: S-TIR technology, 201409– license excl ww €na to Allergopharma to develop antiallergics |
2014-09-02 |
| Bayer–MetaSysX: metabolomic services, 201409–201708 supply services to Bayer CropScience to improve agricultural productivity |
2014-09-01 |
| Berlin Cures–Helmholtz: investment, 201409 Ascenion acquires shares at time of spin-off from Charité + MDC in return for services |
2014-09-01 |
| Berlin Cures–Minverva Partners: investment, 201409 seed investment at time of spin-off from Charité + MDC from Minerva Partners AG |
2014-09-01 |
| CHDI–Evotec: drug discovery services, 201409–201708 collab service extension CDHI funding up to 52 full-time scientists for Huntington’s disease drugs |
2014-09-01 |
| Corgenix Medical–Orgentec: investment, 201409–201503 acquisition of Corgenix for $16m in cash by Orgentec Diagnostika |
2014-09-01 |
| Ipsen–MHH: rec botulinum neurotoxin, 201409– collab r+d with Thomas Binz at Institute for Physiological Chemistry at MHH |
2014-09-01 |
| BASF–Cenix BioScience: biomarker discovery + validation, 201408– supply service €na research framework agreement with Metanomics Health |
2014-08-26 |
| Recipe–Tecan: automated liquid handling, 201408– collab co-marketing of ClinMass LC-MSMS Complete Kits with Freedom EVO platform |
2014-08-26 |
| Covagen–JnJ: investment, 201408 acquisition €na by Cilag GmbH International |
2014-08-25 |
| Eppendorf–Wallinger Ricker Schlotter Tostmann: legal services, 201408 Eppendorf is client of WRST with regard to gradient PCR patent litigation |
2014-08-25 |
| SensoQuest–Rehberg Hüppe: legal services, 201408 SensoQuest is client of RHP with regard to gradient PCR patent litigation |
2014-08-25 |
| InterMune–Roche: investment, 201408– acquisition $8.3b in cash |
2014-08-24 |
| Gamida Cell–Novartis: investment, 201408 acquisiton 14% equity share for $35m by Novartis Pharma AG plus option to fully acquire Gamida Cell |
2014-08-19 |
| MorphoSys–Emergent BioSolutions: antibody cancer drug, 201408– collab developm + commercialisation rights or ES414 outside North America for MorphoSys |
2014-08-19 |
| Lentigen–Miltenyi Biotec: investment, 201408 acquisition lentiviral manufacturing business + assets continuing as Miltenyi sub Lentigen Technology Inc |
2014-08-14 |
| Miltenyi Biotec–Scott Partnership: public relations, 201308 service existent by Phoenix MarCom |
2014-08-14 |
| Bruker–Analytik Jena: investment, 201407–201409 acquisition €na of ICP-MS business from Bruker by AJ |
2014-08-13 |
| RayBiotech–Scienion: print/spotting technology, 201408– distribution €na of Scienion products in China by RayBiotech Inc |
2014-08-13 |
| Seventh Sense Biosystems–Novartis: investment, 201408 financing round Series B totalling $16m incl new investor Novartis |
2014-08-13 |
| Seventh Sense Biosystems–SEVERAL: investment, 201408 financing round Series B $16m from Siemens + Novartis + LabCorp + Flagship + Polaris |
2014-08-13 |
| Seventh Sense Biosystems–Siemens: investment, 201408 financing round Series B totalling $16m incl new investor Siemens Financial Services VC |
2014-08-13 |
| Inocard–Uniqure: investment, 201408 acquisition of Inocard GmbH for €1.5m in cash + €1.5m in shares upfront plus milestones + royalties |
2014-08-11 |
| Biognosys–ETH Zürich: HRM-MS technology, 201408 license to N-glyco-capture technology invented by Ruedi Aebersold |
2014-08-08 |
| Sopat–High-Tech Gründerfonds: investment, 201408 DIVESTMENT sale of shares in Sopat by HTGF to Dr Max Iann Invest GmbH |
2014-08-06 |
| Amptek–AMETEK: investment, 201408 acquisition of Amptek Inc |
2014-08-05 |
| Prosarix–Evolva: investment, 201408 acquisition in shares with 1.2m Evolva shares upfront + 2m shares milestones |
2014-08-04 |
| Santaris Pharma–Roche: investment, 201408 acquisition $250m upfront cash + $200m milestones |
2014-08-04 |
| i3 Membrane–DBU: grant, 201408 existent €250k to support developm of steel-based membrane technology |
2014-08-01 |
| i3 Membrane–Hamburg (govt): investment, 201408 investment by Innovationsstarter Fonds Hamburg + HTGF |
2014-08-01 |
| i3 Membrane–High-Tech Gründerfonds: investment, 201408 investment by HTGF + Innovationsstarter Fonds Hamburg |
2014-08-01 |
| Medineering–High-Tech Gründerfonds: investment, 201408 seed financing round from HTGF + Bayern Kapital + Born2Grow + consortium of business angels |
2014-08-01 |
| Medineering–SEVERAL: investment, 201408 seed financing round from HTGF + Bayern Kapital + Born2Grow + consortium of business angels |
2014-08-01 |
| IBL International–Tecan: investment, 201407 acquisition €29m in cash |
2014-07-30 |
| Riboxx–SEVERAL: investment, 201407–201501 crowdfunding €1m via Seedmatch |
2014-07-30 |
| Artes Biotechnology–Burnet Institute: malaria vaccine, 201407– collab development funded by PATH Malaria Vaccine Initiative (MVI) |
2014-07-29 |
| Artes Biotechnology–Burnet Institute: Metavax VLP technology, 201407 license existent Artes holds international patent rights |
2014-07-29 |
| BIA Separations–Showa Denko: investment, 201407 existent Showa Denko is co-owner of BIO Separations GmbH |
2014-07-29 |
| Showa Denko–BIA Separations: LC columns, 201407– collab expansion Showa Denko takes over BIA sales in Asia-Pacific region |
2014-07-29 |
| Boehringer–Hikma: investment, 201407– acquisition of US generic injectiables business Bedford Laboratories by Hikma from BI |
2014-07-28 |
| Boehringer–Zealand Pharma: peptide drug, 201407– collab + ww excl rights for cardio-metabolic disease €295m milestones + research funding + royalties |
2014-07-28 |
| Butalco–Lesaffre: investment, 201407 acquisition |
2014-07-23 |
| Boehringer–Univ Toronto: drug target discovery, 201407– collab to characterise new drug targets in ubiquitin system |
2014-07-22 |
| InflaRx–SEVERAL: investment, 201407 financing round Series B closing of 2nd + last tranche led by bm-t Thüringen |
2014-07-17 |
| LTS Lohmann Therapie-Systeme–Hopp Group: investment, 201407– acquisition all remaining shares by existent shareholder Dievini Hopp BioTech Holding |
2014-07-17 |
| Metrohm–Waters: chromatography s/w, 201407– collab product integration Empower CDS now can control Metrohm IC systems |
2014-07-17 |
| Paion–Pharmascience: investment, 201407 private placement €4m with 1.27m new shares €3.15/share to Pharmasience Intl Ltd |
2014-07-17 |
| Biosynthetic Technologies–Evonik: investment, 201407 financing round incl Evonik Venture Capital + BP Ventures |
2014-07-16 |
| Immatics–SEVERAL: investment, 201407 financing round Series D 2nd tranche €22m of €34m round Hopp + Strüngmann + Wellington Partners et al |
2014-07-16 |
| Siemens–Danaher: investment, 201407– acquisition Siemens Healthcare Diagnostics' Clinical Microbiology Business by Beckman Coulter |
2014-07-16 |
| Amcure–Germany (govt): grant, 201407 BMBF subsidy via Spinnovator programme managed by Ascenion |
2014-07-15 |
| Amcure–SEVERAL: investment, 201407 financing round Series A €5m led by LBBW Venture Capital GmbH |
2014-07-15 |
| Geisinger–Indivumed: tissue bank, 201407– collab to create cancer research biobanks at Geisinger + Indivumed |
2014-07-15 |
| Fosun–Miacom Diagnostics: molecular diagnostics, 201407– distribution molecular mulitplex sepsis + pneumonia assays by Fosun Diagnostics in CN + Asia |
2014-07-14 |
| Ayoxxa–SEVERAL: investment, 201407 financing round Series B €9m all existing investors + new investors |
2014-07-10 |
| International Council of Biotechnology Associations–BIO Deutschland: biotechnology, 201407 BIO Deutschland is founding member of ICBA |
2014-07-10 |
| International Council of Biotechnology Associations–EuropaBio: biotechnology, 201407 EuropaBio is founding member of ICBA |
2014-07-10 |
| International Council of Biotechnology Associations–Swiss Biotech Association: biotechnology, 201407 SBA is founding member of ICBA |
2014-07-10 |
| International Council of Biotechnology Associations–VCI: biotechnology, 201407 DIB is founding member of ICBA |
2014-07-10 |
| InSphero–Protea Biosciences: tissue analysis, 201407– collab product integration LAESI molecular MS imaging with 3D InSight microtissues |
2014-07-09 |
| Sophia Genetics–Endeavour Vision: investment, 201407 financing round Series B $13.75m led by Invoke Capital + Endeavour Vision + Swisscom |
2014-07-08 |
| Sophia Genetics–Invoke Capital: investment, 201407 financing round Series B $13.75m led by Invoke Capital + Endeavour Vision + Swisscom |
2014-07-08 |
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo-2019.png){kind=logo}
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 650x65px](/banner/iito-20181119-650-065-lse-life-sciences-europe-com.jpg)
1 2 3 ... 30 31 32 ... 53 54 55 
Date![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 650x65px](/banner/iito-20181119-650-065-lsus-life-sciences-usa-com.jpg)
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20111029-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px](/banner/iito-20150801-120-600-lse-life-sciences-europe-com.jpg)
